DNUT KRISPY KREME
Consumer Staples · Russell 2000
Next earnings: not announced yet
What 7 analyst firms say about KRISPY KREME: their latest ratings, price targets and how far the stock is from them. How it works
Analyst window: Latest analyst report within last 1 year
Analyst view · last 1Y
5 rated views · 7 analyst/firm records · 7 firms
Radar score
- Russell 2000 · Top Picks · 6MNot scored · Fewer than 4 price targets in the last 6 months (2)
- Russell 2000 · Safest consensus · 6MNot scored · Fewer than 4 price targets in the last 6 months (2)
Recent analyst activity · last 90 days
Our tracked history has 2 reports on DNUT from 2 analyst firms in the last 90 days (7 firms in the past year).
Ratings, latest available report against the previous one: 1 upgrade and 0 downgrades.
Last 1 year. Latest opinion per identifiable analyst within the last 1 year. BUY / HOLD / SELL each count one current analyst vote; unnamed firm records are a fallback.
| Firm | Analyst | Latest rating | Report date | Latest target (USD) |
|---|---|---|---|---|
| Capital One | Daniel Guglielmo | Buy | 23 Jul 2026 | — |
| Citigroup | Jon Tower | Hold | 27 Feb 2026 | 4.00 USD |
| Evercore ISI | David Palmer | ConflictConflicting reports · excluded | 7 Aug 2026 | 4.00 USD |
| Morgan Stanley | Unnamed analyst | Sell | 20 Jan 2026 | 3.00 USD |
| Singular Research | Research Department | Buy | 1 Jul 2026 | 6.75 USD |
| Weiss Ratings | Unnamed analyst | — | 16 Oct 2026 | — |
| Data feed RESEARCH | Research Team | Hold | 27 Oct 2026 | — |
Partial coverage · checked 6 Nov (6 Nov 2026, 07:00 ET). Some research records could not be refreshed. Cached records retained. Prices stream live during the US session; otherwise stored prices delayed about 15 minutes. A summary of analyst opinion, not investment advice.